Jonathan Mark Hopper
CIK 1626325 · Chief Medical Officer · last filed 2026-06-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.00M
Companies
2
Total Filings
35
Lifetime Open-Market Net
-$6.26M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VCEL | Chief Medical Officer | 80,128 | $37.46 | $3.00M | -$6.26M | 33 | 2026-06-04 |
| OSIRIS THERAPEUTICS, INC. (OSIR) Delisted | Chief Medical Officer | — | — | — | $0 | 2 | 2016-04-15 |
Recent Filings · Page 2 of 4
35 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-02-20 | VCEL | Mixed | +5,237 | -$105.7K | EDGAR |
| 2024-12-03 | VCEL | Mixed | — | -$420.6K | EDGAR |
| 2024-09-05 | VCEL | Mixed | — | -$388.8K | EDGAR |
| 2024-05-21 | VCEL | Mixed | — | -$390.4K | EDGAR |
| 2024-02-26 | VCEL | Grant (A) | — | $0 | EDGAR |
| 2024-02-22 | VCEL | Mixed | +3,969 | -$153.7K | EDGAR |
| 2024-02-13 | VCEL | Mixed | +850 | -$36.8K | EDGAR |
| 2023-11-22 | VCEL | Mixed | — | -$127.2K | EDGAR |
| 2023-02-22 | VCEL | Mixed | +2,215 | -$55.5K | EDGAR |
| 2023-02-14 | VCEL | Mixed | +785 | -$24.6K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.